The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Identifying molecular phenotypes in sepsis: an analysis of two prospective observational cohorts and secondary analysis of two randomised controlled trials
Open accessAbstract
Summary Background: In sepsis and acute respiratory distress syndrome (ARDS) heterogeneity has contributed to difficulty identifying effective pharmacotherapies. In ARDS, two molecular phenotypes (“Hypoinflammatory” and “Hyperinflammatory”) have consistently been identified, with divergent outcomes and treatment responses. In this study, we sought to derive molecular phenotypes in critically ill adult sepsis patients, determine their overlap with prior ARDS phenotypes, and whether they respond differently to treatment in completed sepsis trials. Methods: We used clinical data and plasma biomarkers from two prospective sepsis cohorts [VALID (N=1140) and EARLI (N=818)] in latent class analysis (LCA) to identify the optimal number of classes in each cohort independently. We used validated models trained to classify ARDS phenotypes to evaluate concordance of sepsis and ARDS phenotypes. We applied these models to the PROWESS-SHOCK and VASST trials to assign phenotypes and evaluate heterogeneity of treatment. Findings: A two-class model best fit both VALID and EARLI (p<0.0001). In VALID, 804/1140 (71%) were classified as Hypoinflammatory, and 336/1140 (29%) as Hyperinflammatory; in EARLI, the proportions were 530/818 (65%) and 288/818 (35%) respectively. Comparatively, we observed higher plasma pro-inflammatory cytokines, more vasopressor-use, more bacteraemia, lower Protein C, and higher mortality in the Hyperinflammatory phenotype (p<0.0001 for all). Classifier models indicated strong concordance between sepsis phenotypes and previously identified ARDS phenotypes (area under the curve 0.86-0.96, depending on model). Findings were similar excluding participants with both sepsis and ARDS. In PROWESS-SHOCK, 1142/1680 (68%) were Hypoinflammatory and 538/1680 (32%) Hyperinflammatory, and response to activated protein C differed by phenotype (p=0.0043). In VASST, phenotype proportions were similar to other cohorts; however, no treatment interaction with the type of vasopressor was observed (p=0.72). Interpretation: Molecular phenotypes previously identified in ARDS are also identifiable in multiple sepsis cohorts and respond differently to activated protein C. Molecular phenotypes may represent a treatable trait in critical illness beyond the patient’s syndromic diagnosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The third international consensus definitions for sepsis and septic shock (Sepsis-3).
Singer, M., Deutschman, C. S., Seymour, C. W., Shankar-Hari, M., Annane, D., Bauer, M., Bellomo, R., Bernard, G. R., Chiche, J.-D., Coopersmith, C. M., et al. (2016) · JAMA · doi:10.1001/jama.2016.0287 · Cited by 28,250
Bernard, G. R., Artigas, A., Brigham, K. L., Carlet, J., Falke, K., Hudson, L., Lamy, M., Legall, J. R., Morris, A., & Spragg, R. (1994) · American journal of respiratory and critical care medicine · doi:10.1164/ajrccm.149.3.7509706 · Cited by 6,746
Vasopressin versus Norepinephrine Infusion in Patients with Septic Shock
Russell, J. A., Walley, K. R., Singer, J., Gordon, A. C., Hébert, P. C., Cooper, D. J., Holmes, C. L., Mehta, S., Granton, J. T., Storms, M. M., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa067373 · Cited by 1,924
Self-citationPractitioner’s guide to latent class analysis: Methodological considerations and common pitfalls
Sinha, P., Calfee, C. S., & Delucchi, K. L. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000004710 · Cited by 1,204
Self-citationWhy have clinical trials in sepsis failed?
Marshall, J. C. (2014) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2014.01.007 · Cited by 805
Cited by
Meyer, N. J., & Prescott, H. C. (2024) · New England Journal of Medicine · doi:10.1056/nejmra2403213 · Cited by 395
Metadata
- Authors
- Sinha, P., Kerchberger, V. E., Willmore, A., Chambers, J., Zhuo, H., Abbott, J., Jones, C., Wickersham, N., Wu, N., Neyton, L., Langelier, C. R., Mick, E., He, J., Jauregui, A., Churpek, M. M., Gomez, A. D., Hendrickson, C. M., Kangelaris, K. N., Sarma, A., Leligdowicz, A., Delucchi, K. L., Liu, K. D., Russell, J. A., Matthay, M. A., Walley, K. R., Ware, L. B., & Calfee, C. S.
- Venue
- The Lancet Respiratory Medicine
- Publisher
- Elsevier BV
- Published
- 2023-11
- Volume
- 11
- Issue
- 11
- Pages
- 965-974
- ISSN
- 2213-2600 (ISSN-L)
- OpenAlex
- W4386102775
- Cited by
- 228
- References
- 5
- FWCI
- 38.13
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Identifying molecular phenotypes in sepsis: an analysis of two prospective observational cohorts and secondary analysis of two randomised controlled trials. https://app.cochat.ai/papers/10.1016/s2213-2600(23)00237-0
- The paper
- Sinha, P., Kerchberger, V. E., Willmore, A., Chambers, J., Zhuo, H., Abbott, J., Jones, C., Wickersham, N., Wu, N., Neyton, L., Langelier, C. R., Mick, E., He, J., Jauregui, A., Churpek, M. M., Gomez, A. D., Hendrickson, C. M., Kangelaris, K. N., Sarma, A., . . . Calfee, C. S. (2023). Identifying molecular phenotypes in sepsis: an analysis of two prospective observational cohorts and secondary analysis of two randomised controlled trials. The Lancet Respiratory Medicine. https://doi.org/10.1016/s2213-2600(23)00237-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.